• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Idorsia

parachute chutes
Biotech

Eric Topol boards Flagship as advisor—Chutes & Ladders

Eric Topol boards Flagship as advisor. Idorsia CEO hits the exit. Mestag adds $40 million, two new C-suiters.
Darren Incorvaia , Zoey Becker , Will Maddox Mar 20, 2026 8:30am
exit sign
Favicon Fierce Pharma

Idorsia shares sink after CEO's abrupt departure

Mar 16, 2026 11:00am
cardboard box with office belongings and a desk chair

Nxera lays off staff, pivots pipeline in profitability push

Nov 17, 2025 9:44am
Alps parachute rainbow mountains

Sanofi vaccine vet vaults to GSK—Chutes & Ladders

Jun 13, 2025 8:30am
Asia map globe

Nxera sells lupus drug's APAC rights to Viatris for $10M upfront

Feb 28, 2025 5:10am
Photo of a small belt looped around a blue piggy bank

With no Tryvio buyer, Idorsia recoups $100M from Viatris deal

Feb 26, 2025 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings